Lana Kerr, founder and CEO of Lumisque Skincare, developed the first topical carboxytherapy gel on the consumer market, now the CO2Lift Series.
The original use case of the topical carboxytherapy gel came from a critical need for non-invasive burn treatments in hospitals.
Not only did the patients experience increased healing of their primary burns, they experienced significant improvements to the appearance of their skin.
Those improvements included:
- Reduced fine lines
- Improved wrinkles
- Smaller pores
- Firmer texture
The results were clear—cutaneous carboxytherapy gel had potential for powerful use in anti-aging skincare.
From there, the path forward was clear: